Avera Health   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Sioux Falls SD United States (1897)

Organization Overview

First Clinical Trial
2009
NCT00852046
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Avera McKennan Hospital & University Health Center | Avera Medical Group Neurology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Cardiotoxicity (Phase 2)

Hyperlipidemias (Phase 1)

Myalgia (Phase 1)

Neoplasms (Phase 1)

Obesity (Phase 2)

Weight Loss (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 11